Preparation of HL-60 cell vaccine expressing BCG-HSP70 and its anti-leukemia effect
LI Xiaoling1, LIU Chunlei2, SUN Lirong3
(1. Department of the Third Pediatrics, the Linyi People's Hospital, Linyi 276000, Shandong, China; 2. Department of the Network and Data Center, the Linyi People's Hospital, Linyi 276000, Shandong, China; 3. Department of Pediatric Hematology, the Affiliated Hospital of Medical College, Qingdao University; Qingdao 266003, Shandong, China)
[1] Pui CH，Robison LL，Look AT. Acute lymphoblastic leukemia [J]. Lancet，2008，371(9617)：1030-1043. [2] Pui CH，Carroll WL，Meshinchi S，et al. Biology，risk stratification，and therapy of pediatric acute leukemia：an update [J]. J Clin Oncol，2011，29(5)：551-565. [3] Stow P，Key L，Chen X，et al. Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia [J]. Blood，2010，115(23)：4657-4663. [4] Yang J，Sun LR，Pang XY，et al. Effect of Bacillus Calmette-Guerin on the expansion of dendritic cells from peripheral blood of pediatric patients with leukemia in vitro [J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi，2010，18(5)：1240-1243. [5] Peng ML，Chen M，Ling NX，et al. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70 [J]. Vaccine，2006，24(7)：887-896. [6] Wei MQ，Menoesha A，Good D，et al. Bacterial targeted tumor therapy-drawn of new era [J]. Cancer Lett，2008，259(1)：16-27. [7] Ye J，Chen GS，Song HP，et al. Heat shock protein 70/MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo [J]. Cancer Immunol Immunother，2004，53(9)：825-834. [8] Zhang Y，Li ZJ，Ma ZH，et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene [J]. Cancer Res，2000，60(4)：1035-1042. [9] Onishi H，Kuroki H，Matsumoto K，et al. Monocyte-derived dendritic cells that capture dead tumor cells secret IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappa B autocrine loop [J]. J Cancer Immunol Immunother，2004，53(12)：1093-1100. [10] Cheng WF，Hung CF，et al. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene [J]. J Immunol，2001，166(10)：6218-6226. [11] Hsu KF，Hung CF，Cheng WF，et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen [J]. Gene Them，2001，8(5)：376-383. [12] June CH. Adoptive T cell therapy for cancer in the clinic [J]. J Clin Invest，2007，117(6)：1466-1476. [13] Ahmad M，Rees RC，Ali SA. Escape from immunotherapy possible mechanisms that influence tumor regression/ progression [J]. Cancer Immunol Immunother，2004，53(10)：844-854. [14] Rouas - Freis N，Moreau P，Menier C，et al. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor response [J]. Semin Cancer Biol，2007，17(6)：413-421. [15] Peng ML，Chen M，Ling N，et al. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein [J]. Vaccine，2006，24(7)：887-896. [16] Mizukami S，Kajiwara C，Ishikawa H，et al. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors [J]. Cancer Sci，2008，99(5)：1008-1015. [17] Murshid A，Gong J，Calderwook SK. Heat-shock proteins in cancer vaccines：agents of antigen cross-presentatio [J]. Expert Rev Vaccines，2008，7(7)：1019-1030. [18] Yamaoka A，Guan X，Takemoto S. Development of a novel Hsp70-based DNA vaccine as a multifunction antigen delivery system [J]. J Control Release，2010，142(3)：411-415. [19] Hockertz S. Present and future of cancer vaccines [J]. Toxicology，2005，214(1-2)：151-161. [20] Venken K，Thewissen M，Hellings N，et al. A CFSE based assay for measuring CD4+ CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses [J]. J Immunol Methods，2007，322(1-2)：1-11. [21] Tsuge I，Okumura A，Kondo Y，et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay [J]. Allergol Int，2007，56(2)：149-155. [22] Placek K，Coffre M，Maiella S，et al. Genetic and epigenetic networks controlling T helper 1 cell differentiation [J]. Immunology，2009，127(2)：155-162. [23] Weidnann E，Brieger J，Jahn B，et al. Lactate dehydrogenase release assay：a reliable nonradioactive technique for analysis of cytotoxic lymphocyte-mediate lytic activity against blasts from acute myelocytic leukemia [J]. Ann Hematol，1995，70(3)：153-158. [24] Pirious L，Chilmonczyk S，Genetetet N，et al. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species [J]. Cytometry，2000，41(4)：289-297.
